Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 13/20 | 0.71 |
| ▸ | HDAC2 | Q92769 | 8/20 | 0.71 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.68 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.68 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.68 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.68 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.68 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.68 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.68 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.68 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.68 |
| ▸ | MMP3 | P08254 | 1/20 | 0.61 |
| ▸ | STAT3 | P40763 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13954825 | 0.95 | HDAC1 (0.76) | HDAC1HDAC2HDAC6HDAC3HDAC4 | |
| SCHEMBL8092309 | 0.93 | HDAC1 (0.61) | HDAC1HDAC2HDAC6HDAC3HDAC4 | |
| SCHEMBL8660751 | 0.82 | HDAC1 (0.69) | HDAC1HDAC2HDAC6HDAC3HDAC4 | |
| SCHEMBL17265696 | 0.81 | PPARA (0.61) | HDAC1HDAC2HDAC6HDAC3HDAC4 | |
| SCHEMBL19789098 | 0.81 | HDAC1 (0.97) | HDAC1HDAC2HDAC6HDAC3HDAC4 | |
| SCHEMBL839412 | 0.81 | PPARA (0.61) | HDAC1HDAC2HDAC6HDAC3HDAC4 | |
| SCHEMBL3383144 | 0.81 | HDAC1 (1.00) | HDAC1HDAC2HDAC6HDAC3HDAC4 | |
| SCHEMBL7044810 | 0.81 | HDAC1 (1.00) | HDAC1HDAC2HDAC6HDAC3HDAC4 | |
| SCHEMBL831000 | 0.81 | HDAC1 (0.50) | HDAC1HDAC2HDAC6HDAC3HDAC4 | |
| SCHEMBL13933074 | 0.81 | HDAC1 (0.50) | HDAC1HDAC2HDAC6HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1976795-B1 | SELECTIVE PLACEMENT OF CARBON NANOTUBES THROUGH FUNCTIONALIZATION | IBM (US) | 2016-04-13 | — | — | EP | disclosed |
| US-8859048-B2 | Selective placement of carbon nanotubes through functionalization | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2014-10-14 | — | — | US | disclosed |
| US-8604559-B2 | Method of placing a semiconducting nanostructure and semiconductor device including the semiconducting nanostructure | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2013-12-10 | — | — | US | disclosed |
| US-8283453-B2 | Selective placement of carbon nanotubes through functionalization | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2012-10-09 | — | — | US | disclosed |
| US-8138102-B2 | Method of placing a semiconducting nanostructure and semiconductor device including the semiconducting nanostructure | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2012-03-20 | — | — | US | disclosed |
| US-8084012-B2 | Selective placement of carbon nanotubes through functionalization | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2011-12-27 | — | — | US | disclosed |
| US-20110180777-A1 | METHOD OF PLACING A SEMICONDUCTING NANOSTRUCTURE AND SEMICONDUCTOR DEVICE INCLUDING THE SEMICONDUCTING NANOSTRUCTURE | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2011-07-28 | — | — | US | disclosed |
| US-20100145034-A1 | SELECTIVE PLACEMENT OF CARBON NANOTUBES THROUGH FUNCTIONALIZATION | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-06-10 | — | — | US | disclosed |
| US-20100044678-A1 | METHOD OF PLACING A SEMICONDUCTING NANOSTRUCTURE AND SEMICONDUCTOR DEVICE INCLUDING THE SEMICONDUCTING NANOSTRUCTURE | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-02-25 | — | — | US | disclosed |
| US-20090301349-A1 | SELECTIVE PLACEMENT OF CARBON NANOTUBES THROUGH FUNCTIONALIZATION | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2009-12-10 | — | — | US | disclosed |
| EP-1976795-A1 | SELECTIVE PLACEMENT OF CARBON NANOTUBES THROUGH FUNCTIONALIZATION | International Business Machines Corporation (US) | 2008-10-08 | — | — | EP | disclosed |
| US-20080102213-A1 | Selective placement of carbon nanotubes through functionalization | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2008-05-01 | — | — | US | disclosed |
| WO-2007077078-A1 | SELECTIVE PLACEMENT OF CARBON NANOTUBES THROUGH FUNCTIONALIZATION | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2007-07-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100145034-A1 | SELECTIVE PLACEMENT OF CARBON NANOTUBES THROUGH FUNCTIONALIZATION | NOXO1, EPCAM, SCO2 | HDAC1 2966/4885HDAC2 3581/4885HDAC6 2805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.